Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain

about

Are paraspinous intramuscular injections of botulinum toxin a (BoNT-A) efficient in the treatment of chronic low-back pain? A randomised, double-blinded crossover trial.

P2860

Q45084662-5C22BAEF-BC4A-416A-B2A4-D87D4A2ABB93

P2860

Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain

Item

http://www.wikidata.org/entity/Q39095007

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain

@en

Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain.

@nl

type

Item

label

Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain

@en

Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain.

@nl

prefLabel

Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain

@en

Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain.

@nl

P1476

Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain

@en

P2093

Bahman Jabbari

http://www.w3.org/2001/XMLSchema#string

Duarte Machado

http://www.w3.org/2001/XMLSchema#string

P2860

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors

Neuropathic low back pain in clinical practice

Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy

The global burden of low back pain: estimates from the Global Burden of Disease 2010 study

Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin.

Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.

Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of low back pain: a randomized controlled trial.

Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia.

The pathogenesis of discogenic low back pain.

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

P31

scholarly article

P356

10.3390/TOXINS8120374

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Aditya Kumar

P577

2016-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27983689

http://www.w3.org/2001/XMLSchema#string

P932

5198568

http://www.w3.org/2001/XMLSchema#string

Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain

about

P2860

P2860

Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932